Patents Examined by Young J. Kim
  • Patent number: 10927416
    Abstract: The present invention relates to the field of detection of colorectal cancer (CRC). Specifically it relates to methods for the early detection, risk screening and monitoring of CRC and/or adenomatous polyps in a human subject based on the quantification of one or more 16S rDNA bacterial sequences in feces. It further relates to the use of said bacterial sequences as biomarkers of colorectal cancer and/or adenomatous polyps; to a kit comprising a reagent and instructions for the quantification of said bacterial sequences; and to nucleic acids for the quantification of said 16S rDNA bacterial sequences.
    Type: Grant
    Filed: March 3, 2015
    Date of Patent: February 23, 2021
    Inventors: Mariona Serra Pagès, Librado Jesús García-Gil, Teresa Mas De Xaxars, Xavier Aldeguer Manté
  • Patent number: 10913069
    Abstract: An apparatus for amplifying a nucleic acid sequence in a polymerase chain reaction (PCR) is provided. The apparatus comprises a microprocessor configured to communicatively couple with a user input device and receive instructions from the user input device and implement the received instructions; an electromagnetic radiation (EMR) generator configured to generated EMR at frequencies ranging from 300 THz to 400 THz and communicatively coupled with the microprocessor; a reaction vessel, communicatively coupled with the microprocessor, to house the nucleic acid sequence, necessary reagents to the PCR, and particles comprising a transition metal material, and to receive the EMR generated by the EMR generator; and a temperature sensor communicatively coupled with the reaction vessel and the microprocessor.
    Type: Grant
    Filed: January 10, 2019
    Date of Patent: February 9, 2021
    Assignee: NATIONAL CHENG KUNG UNIVERSITY
    Inventors: Dar-Bin Shieh, Chih-Chia Huang, Chen-Min Chang, Tsung-Ju Li, Po-Yang Chang, Ming-Chi Hsieh
  • Patent number: 10900085
    Abstract: The present invention relates to a method for the diagnosis of colorectal cancer from a sample of blood or blood fractions, and to a kit for said diagnosis.
    Type: Grant
    Filed: May 23, 2016
    Date of Patent: January 26, 2021
    Assignee: Alma Mater Studiorum—Università di Bologna
    Inventors: Rossella Solmi, Gabriella Mattei, Giampaolo Ugolini, Maria Rodia, Mattia Lauriola, Isacco Montroni
  • Patent number: 10900066
    Abstract: The present technology provides for an apparatus for detecting polynucleotides in samples, particularly from biological samples. The technology more particularly relates to microfluidic systems that carry out PCR on nucleotides of interest within microfluidic channels, and detect those nucleotides. The apparatus includes a microfluidic cartridge that is configured to accept a plurality of samples, and which can carry out PCR on each sample individually, or a group of, or all of the plurality of samples simultaneously.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: January 26, 2021
    Assignee: HandyLab, Inc.
    Inventors: Kalyan Handique, Sundaresh N. Brahmasandra, Karthik Ganesan, Jeff Williams
  • Patent number: 10888830
    Abstract: Provided herein are biomolecular hybridization devices comprising a substrate with a permanently and covalently attached surface of functional groups and an adsorbed monolayer of unmodified, single-stranded oligonucleotides all of which are 10 to about 24 bases in length as a saturated film of constrained oligonucleotides on the surface via direct non-covalent phosphate-surface adsorptive contact of substantially all phosphate groups of each oligonucleotide. The constrained oligonucleotides are effective to dissociably hybridize to a complementary single-stranded nucleic acid with asymmetric, non-helical base pairing and without oligonucleotide dissociation from the surface of the device. Also, provided are methods for hybridizing solution-state target nucleic acids to probe nucleic acids and for identifying a nucleotide sequence to which a nucleotide-binding protein binds using the biomolecular hybridization devices.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: January 12, 2021
    Assignees: Genomics USA, Inc., Baylor College of Medicine
    Inventors: Michael E. Hogan, Joseph G. Utermohlen, Frederick H. Eggers, Krishna Jayaraman
  • Patent number: 10882045
    Abstract: Examples include polymerase chain reaction (PCR) devices. Example PCR devices comprise a fluid input, ejection nozzles, and a set of microfluidic channels that fluidly connect the fluid input and the ejection nozzles. Each microfluidic channel comprises a reaction chamber, and examples further comprise at least one heating element, where the at least one heating element is positioned in the reaction chamber of each microfluidic channel. The at least one heating element is to heat fluid in the reaction chamber of each fluid channel. The device may eject fluid via the ejection nozzles.
    Type: Grant
    Filed: January 8, 2016
    Date of Patent: January 5, 2021
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Erik D. Torniainen, Alexander Govyadinov, Pavel Kornilovich, David P. Markel
  • Patent number: 10876165
    Abstract: The present invention relates to the field of detection of colorectal cancer (CRC). Specifically it relates to methods for the early detection, risk screening and monitoring of CRC and/or adenomatous polyps in a human subject based on the quantification of one or more 16S rDNA bacterial sequences in feces. It further relates to the use of said bacterial sequences as biomarkers of colorectal cancer and/or adenomatous polyps; to a kit comprising a reagent and instructions for the quantification of said bacterial sequences; and to nucleic acids for the quantification of said 16S rDNA bacterial sequences.
    Type: Grant
    Filed: March 3, 2015
    Date of Patent: December 29, 2020
    Inventors: Mariona Serra Pagès, Librado Jesús García-Gil, Teresa Mas De Xaxars, Xavier Aldeguer Manté
  • Patent number: 10876170
    Abstract: The present disclosure relates to methods for detecting and targeting genomic rearrangements, in particular gene fusion events, by targeting a DNA molecule of interest with a set or pool of primers, wherein the forward primers and reverse primers produce a PCR amplification product when a genomic rearrangement is present. The present disclosure also relates to methods of bioinformatic analysis to determine whether or not the detection of an amplification product from the selective PCR is actually indicative of the presence of a gene fusion. The present disclosure also related to related methods of diagnosis and treatment of diseases and conditions associated with such genomic rearrangements, in particular cancers, such as lung cancer.
    Type: Grant
    Filed: June 18, 2018
    Date of Patent: December 29, 2020
    Assignee: INIVATA LTD.
    Inventors: Samuel Woodhouse, Stefanie Lensing, Tim Forshew, Vincent Plagnol, Matthew Edward Smith, Karen Howarth, Michael Epstein
  • Patent number: 10871485
    Abstract: Kits, compositions, and methods for labeling target materials or target analytes are considered. The composition can include one or more affinity molecules indirectly conjugated to one or more detection moieties. The kit can be used to detect a single biomarker or multiple biomarkers. The kit can be used to perform a single round of labeling or multiple rounds of labeling.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: December 22, 2020
    Assignee: RareCyte, Inc.
    Inventors: Daniel E. Campton, Yao Sun
  • Patent number: 10870882
    Abstract: DNA is sequenced by (a) independently sequencing first and second strands of a dsDNA to obtain corresponding first and second sequences; and (b) combining the first and second sequences to generate a consensus sequence of the dsDNA. By independently sequencing first and second strands the error probability of the consensus sequence approximates a multiplication of those of the first and second sequences.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: December 22, 2020
    Assignee: Board of Regents, The University of Texas System
    Inventors: Zbyszek Otwinowski, Dominika Borek
  • Patent number: 10870872
    Abstract: The disclosure provides methods for making a polynucleotide wherein the addition of nucleotides can be physically, chemically and/or enzymatically controlled. The methods include combining a selected nucleotide, cations, an error prone or template independent DNA polymerase at a reaction site including an initiator sequence attached thereto and having a 3? terminal nucleotide, wherein the reaction reagents can be modulated and under conditions that allow covalent addition of one or more of a selected nucleotide to the 3? terminal nucleotide such that the selected nucleotide becomes a 3? terminal nucleotide, and repeating the addition step until the polynucleotide is formed.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: December 22, 2020
    Assignee: President and Fellows of Harvard College
    Inventors: Henry Hung-yi Lee, George M. Church, Reza Kalhor
  • Patent number: 10865454
    Abstract: Methods for detecting HAV in a biological sample are provided, comprising amplifying a target nucleic acid comprising the sequence of HAV in a reaction mixture. The reaction mixture comprises a biological sample which may contain the target nucleic acid and set of oligonucleotides. The invention also provides kits for the detection of HAV.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: December 15, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Hermann Leying, Ning Lu, Nick Newton, Andreas Wolfelschneider, Karen Young, Dirk Zimmermann
  • Patent number: 10844441
    Abstract: Disclosed herein are methods and compositions for human identification using polymorphisms in the Penta E short tandem repeat locus. These newly disclosed polymorphisms are significant in preventing allelic drop out.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: November 24, 2020
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventor: Chang Zhong
  • Patent number: 10837049
    Abstract: The present invention regards a variety of methods and compositions for whole genome amplification and whole transcriptome amplification. In a particular aspect of the present invention, there is a method of amplifying a genome comprising a library generation step followed by a library amplification step. In specific embodiments, the library generating step utilizes specific primer mixtures and a DNA polymerase, wherein the specific primer mixtures are designed to eliminate ability to self-hybridize and/or hybridize to other primers within a mixture but efficiently and frequently prime nucleic acid templates.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: November 17, 2020
    Assignee: Takara Bio USA, Inc.
    Inventors: Emmanuel Kamberov, Tong Sun, Eric Bruening, Jonathon H. Pinter, Irina Sleptsova, Takao Kurihara, Vladimir L. Makarov
  • Patent number: 10837065
    Abstract: Embodiments of present disclosure are directed to methods for amplifying nucleic acid, comprising two steps: a first step of preparing a reaction mixture comprising the target nucleic acid and a second step of processing the reaction mixture in a thermocycler. During a first phase of the processing step, the thermocycler may be configured to heat the reaction mixture to a first temperature and cool the reaction mixture to a second temperature repeatedly for a first plurality of cycles. During the first phase, fluorescence probes do not anneal to template strands and do not emit fluorescence signals. During a second phase of the processing step, the thermocycler may heat the reaction mixture to a third temperature and cool the reaction mixture to a fourth temperature repeatedly for a second plurality of cycles.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: November 17, 2020
    Assignee: TETRACORE, INC.
    Inventors: William M. Nelson, Kyle Armantrout, Tracy Calvin Fecteau
  • Patent number: 10837050
    Abstract: Improvements on the basic method used for BEAMing increase sensitivity and increase the signal-to-noise ratio. The improvements have permitted the determination of intrinsic error rates of various DNA polymerases and have permitted the detection of rare and subtle mutations in DNA isolated from plasma of cancer patients.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: November 17, 2020
    Assignee: The Johns Hopkins University
    Inventors: Bert Vogelstein, Frank Diehl, Kenneth W. Kinzler, Meng Li
  • Patent number: 10801056
    Abstract: The present invention relates to a kit for detecting miRNA and a method for detecting miRNA using the kit. According to the miRNA detection kit and method of the present invention, it is possible to detect a certain miRNA in a quick and accurate manner, and it also possible to perform multiplex analysis capable of detecting a plurality of miRNAs at the same time.
    Type: Grant
    Filed: August 8, 2017
    Date of Patent: October 13, 2020
    Assignee: HEIMBIOTEK INC.
    Inventor: Jae Hoon Lee
  • Patent number: 10794925
    Abstract: Systems, methods, and devices for discretizing and analyzing fluidic samples are provided. In one aspect, a microfluidic array for discretizing a fluidic sample comprises one or more flow channels and a plurality of fluidic compartments in fluidic communication with the one or more flow channels. In another aspect, a system for discretizing and analyzing fluidic samples comprises a rotor assembly shaped to receive a microfluidic device.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: October 6, 2020
    Assignee: University of Washington
    Inventors: Daniel T. Chiu, Bryant S. Fujimoto, Jason E. Kreutz
  • Patent number: 10787694
    Abstract: The present invention provides methods and compositions for improving the efficiency of nucleic acid amplification reactions. The invention encompasses hybrid polymerases that show increased processivity over wild type polymerases as well as decreased exonucleases activity. The invention also encompasses methods, compositions and kits for conducting nucleic acid synthesis and amplification reactions in which non-specific amplification of primers is reduced.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: September 29, 2020
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Xiao-Song Gong, John Sullivan, Rongdian Fu, Yan Wang, Evan H. Bursey, Man Cheng
  • Patent number: 10781494
    Abstract: The present invention relates to the identification of microorganisms from an environmental sample, and in particular to the rapid identification of Listeria spp. The methods and kits described herein provide a method of detecting Listeria spp. without the need for an enrichment step.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: September 22, 2020
    Assignee: NEOGEN CORPORATION
    Inventors: John Nelson, Preetha Biswas, Lei Zhang, Mark A. Mozola, Lisa Pinkava, David Brookman, Edan Robert Hosking